top of page

New blood test gives high accuracy screen for Alzheimer's disease

A new blood test called p-tau217 shows promise as an Alzheimer's disease biomarker, and when used in a two-step workflow very high accuracy to either identify or exclude brain amyloidosis, the most important and earliest pathology. That is an innovation now presented by researchers at the University of Gothenburg, together with colleagues at University of Lund and in Montreal, Canada.




Commentaires


Featured Posts
Recent Posts
Archive
Search By Tags
bottom of page